Philipp E Bartko
Overview
Explore the profile of Philipp E Bartko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mueller M, Charwat-Resl S, Schulze-Bauer H, Nguyen C, Niessner A, Bartko P, et al.
Atherosclerosis
. 2025 Feb;
402:119106.
PMID: 39914324
Background And Aims: Local variations of vascular strain may be related to the development of atherosclerotic lesions. Whether vascular strain of peripheral arteries without manifest atherosclerosis is affected by diabetes...
2.
Dannenberg V, Demirel C, Bartunek A, Bartko P
JACC Case Rep
. 2025 Jan;
30(2):102760.
PMID: 39886427
Mitral and tricuspid regurgitation, linked to high morbidity and mortality, are increasingly treated with interventional edge-to-edge repair, showing excellent results in favorable anatomy. Recently, interventional valve replacement strategies have emerged....
3.
Halavina K, Koschatko S, Jantsch C, Autherith M, Petric F, Rockel A, et al.
JACC Adv
. 2025 Jan;
4(2):101544.
PMID: 39886314
Background: Degenerative severe aortic stenosis (AS) is treated by valve replacement to improve outcome. Despite diagnostic advancements, many AS patients are still diagnosed late with advanced heart failure. Objectives: The...
4.
Comparative Assessment of CMR-Determined Extracellular Volume Metrics in Predicting Adverse Outcomes
Mascherbauer K, Kronberger C, Dona C, Koschutnik M, Dannenberg V, Poledniczek M, et al.
J Clin Med
. 2025 Jan;
14(2.
PMID: 39860388
Extracellular volume (ECV) by cardiovascular magnetic resonance (CMR) imaging is associated with disease burden and clinical outcomes. Recent studies in patients with valvular heart disease (VHD) have suggested that the...
5.
Hamzaraj K, Demirel C, Gyongyosi M, Bartko P, Hengstenberg C, Frey B, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768599
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) requires advanced techniques and prolonged procedural efforts, often necessitating high contrast volumes, which may increase the risk of contrast-associated acute kidney...
6.
Rudolph F, Gercek M, Kirchner J, Ivannikova M, Friedrichs K, Rudolph T, et al.
Clin Res Cardiol
. 2024 Dec;
114(2):290.
PMID: 39652120
No abstract available.
7.
Dannenberg V, Zschocke F, Halavina K, Mascherbauer K, Heitzinger G, Koschutnik M, et al.
Eur J Clin Invest
. 2024 Dec;
55(3):e14367.
PMID: 39623565
Background: Severe tricuspid regurgitation (TR) is associated with high morbidity and mortality. Isolated TR, defined as TR without overt heart disease, is typical and offers limited cardiac treatment options other...
8.
Demirel C, Hamzaraj K, Fangl J, Hemetsberger R, Krychtiuk K, Roth C, et al.
Int J Cardiol
. 2024 Nov;
421():132758.
PMID: 39613041
Background: ABO blood group's influence on cardiovascular risk, particularly in venous thromboembolism and coronary artery disease (CAD), is well-studied, with non-O blood groups associated with heightened CAD risk. However, its...
9.
Demirel C, Hamzaraj K, Seeber A, Hemetsberger R, Koschatko S, Jantsch C, et al.
Heart Lung
. 2024 Nov;
70:8-13.
PMID: 39541607
Background: Preprocedural evaluation, including frailty estimation, is crucial in managing patients undergoing Transcatheter Aortic Valve Replacement (TAVR). This involves mandatory computed tomography (CT) scans for assessing body composition parameters. The...
10.
Rudolph F, Gercek M, Kirchner J, Ivannikova M, Friedrichs K, Rudolph T, et al.
Clin Res Cardiol
. 2024 Sep;
114(2):251-260.
PMID: 39316085
Background And Objective: Within recent years, transcatheter tricuspid edge-to-edge repair (T-TEER) has emerged as a safe and effective treatment option in patients with secondary tricuspid regurgitation (TR). However, for primary...